Efficacy, safety, and tolerability of albendazole and ivermectin based regimens for the treatment of microfilaraemic loiasis in adult patients in Gabon: A randomized controlled assessor blinded clinical trial

ConclusionThe 5-week regimen of albendazole or a 3-week regimen of albendazole followed by ivermectin were most efficacious to reduce microfilaraemia. All therapeutic regimens were well tolerated and safe. Trial registrationTrial registered at the Pan-African Clinical Trials Registry: PACTR201807197019027.
Source: PLoS Neglected Tropical Diseases - Category: Tropical Medicine Authors: Source Type: research